These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
934 related articles for article (PubMed ID: 18191382)
1. The sphingolipid salvage pathway in ceramide metabolism and signaling. Kitatani K; Idkowiak-Baldys J; Hannun YA Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382 [TBL] [Abstract][Full Text] [Related]
2. The effect of altered sphingolipid acyl chain length on various disease models. Park WJ; Park JW Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Kihara A; Mitsutake S; Mizutani Y; Igarashi Y Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104 [TBL] [Abstract][Full Text] [Related]
4. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways. Hajj C; Becker-Flegler KA; Haimovitz-Friedman A Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313 [TBL] [Abstract][Full Text] [Related]
5. Ceramide synthases at the centre of sphingolipid metabolism and biology. Mullen TD; Hannun YA; Obeid LM Biochem J; 2012 Feb; 441(3):789-802. PubMed ID: 22248339 [TBL] [Abstract][Full Text] [Related]
6. Ceramide synthases as potential targets for therapeutic intervention in human diseases. Park JW; Park WJ; Futerman AH Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978 [TBL] [Abstract][Full Text] [Related]
7. An overview of sphingolipid metabolism: from synthesis to breakdown. Gault CR; Obeid LM; Hannun YA Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643 [TBL] [Abstract][Full Text] [Related]
8. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease. Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711 [TBL] [Abstract][Full Text] [Related]
9. Sphingolipids in mammalian cell signalling. Ohanian J; Ohanian V Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056 [TBL] [Abstract][Full Text] [Related]
10. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386 [TBL] [Abstract][Full Text] [Related]
12. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells. Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634 [TBL] [Abstract][Full Text] [Related]
13. Introduction to tools and techniques for ceramide-centered research. Kitatani K; Luberto C Adv Exp Med Biol; 2010; 688():276-85. PubMed ID: 20919662 [TBL] [Abstract][Full Text] [Related]
14. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Tani M; Ito M; Igarashi Y Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225 [TBL] [Abstract][Full Text] [Related]
16. Novel agents targeting bioactive sphingolipids for the treatment of cancer. Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584 [TBL] [Abstract][Full Text] [Related]